Ambient AI medical scribes use passive voice recognition and AI processing to generate clinical documentation during patient visits, reducing the time physicians spend on administrative tasks after the encounter.
Six companies dominate ambient clinical documentation and the marketing language is nearly identical across all of them. The questions that actually separate them are about correction time, retention, specialty fit, and coding behavior.
A human scribe and an ambient AI scribe produce a similar artifact through very different arrangements of cost, judgment, and accountability. The comparison that matters is not accuracy, it is what each one absorbs when the encounter gets complicated.
Predictive analytics in healthcare covers two very different activities with very different risk profiles. The documented failures are not failures of accuracy, they are failures of validation population, outcome definition, and what happens after go-live.
Most healthcare predictive models are not bought as products. They arrive inside the EHR or get built internally, which is why the usual software evaluation process misses them entirely.
AI in radiology has moved beyond pilot programs. FDA-cleared AI tools are now used in clinical settings for chest X-ray interpretation, mammography screening, stroke detection, and pulmonary embolism triage. Here is the current state of the field.
Some healthcare AI companies have their own listed shares. Others belong to public parents or remain private; this guide separates those relationships.
Most healthcare AI return figures are modeled rather than measured. Here is where published economic evidence actually exists, what it measures, and how to build a number for your own hospital.
A dated tracker of state laws governing AI in healthcare: what is enforceable today, what takes effect between October 2026 and July 2027, and the four obligations that repeat across states.
An AI governance framework for a hospital is not a policy document. It is a standing decision process that says who approves an AI tool, what evidence they require, who owns it after go-live, and what triggers turning it off. Most of what gets published as a framework skips the last two.
Responsible AI claims become useful when a hospital can verify who was studied, what the clinician sees, who owns failures, and what gets measured after launch.
There is no single 'AI in healthcare' law. What actually governs a healthcare AI tool today is a patchwork: FDA oversight if it qualifies as a medical device, HIPAA if it touches protected health information, ONC's HTI-1 transparency rule if it's in certified health IT, and voluntary frameworks like NIST's AI RMF filling the rest of the gap.
A practical way to evaluate healthcare AI vendors by the job they do, the evidence they carry, the data they touch, and the work that remains after launch.
A hub for the healthcare AI infrastructure strategy layer: data locality, local inference, IBM Power 11, IBM i modernization, clinical governance, and hospital AI readiness.
Hospital AI strategy cannot stop at software selection. Clinical AI, claims automation, EHR matching, imaging workflows, and AI governance all depend on infrastructure that can keep data close, systems available, and operational control visible.